Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

December 31,

2022

January 1,
2022

Assets

Current assets:

   Cash and cash equivalents

$   499,915

$1,074,623

   Short-term investments

692,024

964,582

   Accounts receivable, net

71,437

98,313

   Inventories

100,417

49,307

   Prepaid expenses and other current assets

97,570

51,748

Total current assets

1,461,363

2,238,573

Property and equipment, net

152,016

146,516

Goodwill

376,389

376,389

Other intangible assets, net

84,907

118,978

Other assets, net

94,753

77,839

Total assets

$2,169,428

$2,958,295

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     89,860

$     47,327

   Current portion of convertible debt, net

--

450,599

   Deferred revenue and returns liability

6,780

13,849

   Other current liabilities

89,136

157,052

Total current liabilities

185,776

668,827

Convertible debt, net

529,573

--

Other non-current liabilities

49,071

77,044

Total liabilities

764,420

745,871

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      31,994 and 38,481 shares issued and outstanding at

      December 31, 2022 and January 1, 2022, respectively

3

4

   Retained earnings

1,415,693

2,214,839

   Accumulated other comprehensive loss

(10,688)

(2,419)

Total stockholders' equity

1,405,008

2,212,424

Total liabilities and stockholders' equity

$2,169,428

$2,958,295